Candidate genes.

refine your query
genesymbol type description chr. startpos endpos synonyms
BIRC3 protein-coding baculoviral IAP repeat containing 3 11 102188194 102208465 RNF49, MALT2, API2, HIAP1, AIP1, MIHC, HAIP1, CIAP2, c-IAP2, IAP-1
  links NCBI   ENSEMBL  SwissProt  GeneCards   STRING   PubMed  create primers for all transcripts
  KEGG pathways Ubiquitin mediated proteolysis, Apoptosis, Focal adhesion, NOD-like receptor signaling pathway, Pathways in cancer, Small cell lung cancer
  PFAM Inhibitor of Apoptosis domain, Caspase recruitment domain
  InterPro domains CARD domain, Baculoviral inhibition of apoptosis protein repeat, Zinc finger, RING-type, Death-like domain
  paralogs BIRC2 (71%), XIAP (32%), NAIP (22%), NLRC4 (10%), BIRC7 (17%), BIRC8 (16%)
  • Hyperhidrosis
  • Weight loss
  • Mediastinal lymphadenopathy
  • Constipation
  • Abnormality of the gastric mucosa
  • Lacrimation abnormality
  • Nausea and vomiting
  • Hematological neoplasm
  • Abnormality of temperature regulation
  • Inflammatory abnormality of the eye
  • Pulmonary infiltrates
  • Recurrent respiratory infections
  • Abnormality of the thyroid gland
  • Abdominal pain
    CLONING Baculovirus inhibitors of apoptosis (IAPs) act in insect cells to prevent cell death. Uren et al. (1996) isolated cDNAs encoding 3 human IAP homologs, which they designated MIHC (mammalian IAP homolog C), MIHB (BIRC2; 601712), and MIHA (XIAP; 300079). All 3 predicted proteins contain 3 BIR (baculovirus IAP repeat) domains in the N-terminal region and a single RING finger domain close to the C terminus. MIHC shares 73% and 43% identity with MIHB and MIHA, respectively. Independently, Liston et al. (1996) cloned cDNAs encoding BIRC3, which they called HIAP1, BIRC2, which they called HIAP2, and XIAP. By Northern blot analysis, Liston et al. (1996) found that HIAP1 is expressed as a 6.5-kb mRNA in fetal lung and kidney and in adult lymphoid tissues. GENE FUNCTION Uren et al. (1996) found that unlike MIHA and MIHB, MIHC did not inhibit apoptosis caused by ICE (147678) overexpression. However, Liston et al. (1996) determined that expression of all 3 human IAPs in mammalian cells inhibited serum deprivation-induced apoptosis and apoptosis triggered by treatment with menadione, a potent inducer of free radicals. Uren et al. (1996) reported that both MIHB and MIHC bound to the tumor necrosis factor receptor-associated factors TRAF1 (601711) and TRAF2 (601895) in yeast 2-hybrid assays, suggesting that IAP proteins that inhibit apoptosis may do so by regulating signals required for activation of ICE-like proteases. Dai et al. (2003) used restriction landmark genomic scanning (RLGS) to identify novel amplified sequences in primary lung carcinomas and lung cancer cell lines. Enhanced RLGS fragments indicative of gene amplification were observed in tumors and cell lines of both nonsmall cell lung cancer (211980) and small cell lung cancer (182280). The authors identified a novel amplicon on chromosome 11q22 which was refined to 0.92 Mb in 1 patient sample. Immunohistochemistry and Western blot analysis identified BIRC2 (601712) and BIRC3 as potential oncogenes in this region, since both are overexpressed in multiple lung cancers with or without higher copy numbers. Using differential display, Horrevoets et al. (1999) found that cytokines induced expression of HIAP1 in cultured human umbilical vein endothelial cells. HIAP1 was an early response gene, with expression peaking between 1.5 and 3 hours. TNF-alpha (191160), a proapoptotic protein, also induced HIAP1 expression. In situ hybridization detected HIAP1 in endothelial cells of atherosclerotic aorta and iliac arteries, coinciding with MCP1 (CCL2; 158105) expression, but not in normal arteries or arteries lacking monocyte/macrophage infiltrates. Cytokine signaling is thought to require assembly of multicomponent signaling complexes at cytoplasmic segments of membrane-embedded receptors, in which receptor-proximal protein kinases are activated. Matsuzawa et al. (2008) reported that, upon ligation, CD40 (109535) formed a complex containing adaptor molecules TRAF2 and TRAF3 (601896), ubiquitin-conjugating enzyme UBC13 (UBE2N; 603679), CIAP1 and CIAP2, IKK-gamma (IKBKG; 300248), and MEKK1 (MAP3K1; 600982). TRAF2, UBC13, and IKK-gamma were required for complex assembly and activation of MEKK1 and MAP kinase cascades. However, the kinases were not activated unless the complex was translocated from the membrane to the cytosol upon CIAP1/CIAP2-induced degradation of TRAF3. Matsuzawa et al. (2008) proposed that this 2-stage signaling mechanism may apply to other innate immune receptors and may account for spatial and temporal separation of MAPK and IKK signaling. MAPPING By analysis of a somatic cell hybrid panel, Liston et al. (1996) mapped the BIRC3 gene to chromosome 11. Rajcan-Separovic et al. (1996) used fluorescence in situ hybridization to map the BIRC3 gene to the boundary of chromosome 11q22 and 11q23. Since the BIRC2 gene is also localized to this region, the authors speculated that these genes arose by tandem duplication. ANIMAL MODEL In mice lacking Birc2, Birc3, or Ripk2 (603455), or HT29 cells lacking Birc2 or Birc3 by RNAi depletion, Bertrand et al. (2009) showed that Birc2 and Birc3 are required for ubiquitination of Ripk2 and that these molecules are required for Ripk2-dependent activation of Mapk and Nfkb (164011) signaling pathways in response to Nod1 (605980) and Nod2 (605956) agonists. Cytokine and chemokine production was also reduced in macrophages from Birc2-null and Birc3-null mice. The reduced inflammatory response also resulted in resistance to peritonitis induction. Dextran sulfate sodium-induced colitis was not prevented by muramyl dipeptide Nod2 activation in mice with Ripk2 and Birc3 deficiency. Bertrand et al. (2009) concluded that cellular IAPs are key regulators of NOD innate immunity signaling.
    See report at OMIM's website.

      OrphaNet MALT lymphoma   fusion gene (assessed)
  • REVIEW: Genetic alterations involving API2 underlying the pathogenesis of MALT lymphoma
  • promotes tumor cell survival in mesothelioma
  • Interferon-beta therapy exerts a regulatory effect on peripheral T lymphocytes through an anti-apoptosis mechanism that involves the downregulation of cellular Inhibitor of Apoptosis Protein expression.
  • These results indicate that IAPs alone are not the main factor responsible for the resistance of non-small-cell lung cancer cells to treatment.
  • pathway and antiapoptotic effect of up-regulation of cIAP2 by G-CSF in neutrophils, and overexpression of cIAP2 in chronic neutrophilic leukemia
  • Cellular inhibitors of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO.
  • Fuses with MALT1 and defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
  • cIAP1 and cIAP2 are potential oncogenes and are overexpressed in multiple lung cancers with or without higher copy numbers
  • these results indicate that unlike Smac/DIABLO, Omi/HtrA2's catalytic cleavage of IAPs is a key mechanism for it to irreversibly inactivate IAPs and promote apoptosis.
  • cIAP-2 is an important regulator of apoptosis in bladder cancer and its overexpression may make tumours less susceptible to therapy involving apoptosis.
  • overexpression of PKC delta induced cIAP-2 promoter activity and increased NF-kappa B transactivation, suggesting regulation of cIAP-2 expression by a PKC delta/NF-kappa B pathway
  • copy numbers of API2-MALT1 do not reflect tumor cell proportions, and that the number of copies of API2-MALT1 in a tumor cell is different for each clinical sample.
  • Relative risk of death was lower for cytoplasmic c-IAP1, cytoplasmic c-IAP2, and nuclear c-IAP2 expression. It was higher for nuclear c-IAP1 expression.
  • levels of c-IAP1 and c-IAP2 are regulated by Smac/DIABLO through the ubiquitin/proteasome pathway
  • PR39 causes an increase in gene expression from a transfected human cDNA IAP-2 promoter in BAEC cells. PR39-induced increase in the level of IAP-2 mRNA in BAECs is due to an increase in transcription rate and mRNA stability.
  • decreased cIAP2 may play a role in increased apoptosis in aged humans
  • cAMP can induce c-IAP2 expression in colon cancer cells through CREB phosphorylation and CRE-dependent transcription in a manner that involves activation of ERK1/2 and p38 MAPK
  • X-linked XIAP is present in Chronic lymphocytic leukemia cells and is up-regulated in conditions where apoptosis is prevented.
  • Detection of API2-MALT1 fusion transcripts is useful for evaluating the prognosis and clinical behavior of the MALT lymphoma.
  • NF-kappa B signaling, once activated in a CD40-dependent immune response, is maintained and enhanced through deregulation of MALT1 or formation of an API2-MALT1 fusion
  • API2-MALT1 transcript was confirmed to be associated with the levels of apoptosis and API2 of MALT lymphoma.
  • cIAP2 expression is up-regulated by IFN-alpha and IFN-gamma through the JAK2-STAT3 pathway, and increased expression of the cIAP2 protein may contribute to an IFN-alpha- and IFN-gamma-mediated antiapoptotic effect on human neutrophils.
  • Upregulation of c-IAP2 by E6 and E7 may confer resistance to apoptosis that is necessary for sustained growth of some HPV16- and HPV18-positive cancer cells.
  • Taken together, our results strongly indicated that API2-MALT1 possesses a novel mechanism of self-activation by up-regulating its own expression in t(11;18)(q21;q21)-carrying MALT lymphomas.
  • IAP-2, XIAP, and survivin may make an important contribution to the resistance to the apoptotic effect of cisplatin in prostate cancer
  • cIAP1 and cIAP2 bind but do not inhibit caspases
  • demonstrates, for the first time, that BIRC3 (anti-apoptotic protein), COL3A1 (matrix protein synthesis), and CXCL3 (chemokine) were up-regulated in the thrombin-stimulated human umbilical vein endothelial cells
  • Common translocation in MALT lymphoma results in a fusion of the cIAP2 region on chromosome 11q21 with the MALT1 gene on chromosome 18q21.
  • cIAP2 is an inhibitor of antigenic signaling and implicate its dysfunction in MALT lymphomas.
  • Tax-mediated HIAP-1 overexpression is required to suppress endogenous apoptosis and, therefore, is essential for the survival of HTLV-1-transformed lymphocytes
  • Eosinophils of hypereosinophilic syndrome (HES) patients (but not normal eosinophils) express high levels of cellular IAP-2 (cIAP-2) and inhibit the caspase cascade in HES eosinophils.
  • results reveal a physiological function of cIAP2, identify Bcl10 upregulation as a unifying molecular mechanism for MALT lymphomas, and define the mechanism and effects of this upregulation in t(11;18)-positive mucosa-associated lymphoid tissue lymphomas
  • Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cells.
  • Cell cycle-dependent G2/M-phase-specific cIAP2 expression is enhanced by NF-kappaB activation, and selective down-regulation of cIAP2 causes cells blocked in mitosis with nocodazole to become susceptible to apoptosis.
  • the t(11, 18)(q21;q21) translocation creating the c-IAP2.MALT1 fusion protein activates NF-kappaB independently of TRAF1 AND TRAF2 and contributes to human malignancy in the absence of signaling adaptors that might otherwise regulate its activity
  • Differential expression of IAPs in B-cell lymphomas suggests differences in pathogenesis that may have implications for novel treatment strategies targeting IAPs.
  • Persistent infection of epithelial cell line with Chlamydophila pneumoniae resulted in the upregulation of the NF-kappaB regulated inhibitor of apoptosis protein 2 but not inhibitor of apoptosis protein 1 and apoptosis resistance.
  • In particular, the stability of cIAP-2 is modulated by the presence of X-linked IAP and their interaction is stabilized in infected cells.
  • TNF-alpha induced expression of c-IAP1 and c-IAP2 via MAP kinases, but not via NF-kappaB, and that MAP kinases participated in the inhibition of apoptosis by induction of c-IAPs in TNF-alpha-stimulated endothelial cells
  • Trp323 of BIR3 plays a pivotal role both in maintaining necessary conformation for caspase-9 interaction and to a lesser extent, recognition of Smac-type peptide.
  • Bortezomib inhibited expression of cIAP-1, cIAP-2, and XIAP, which are regulated by NF-kappaB and function as inhibitors of apoptosis.
  • Levels of IAP-2 and Bax were decreased in A375 cells and HIF-1alpha was increased during hypoxia.
  • Inflammation during active ulcerative colitis causes an upregulation of cIAP2 in regenerating epithelium, rendering the cells less susceptible to Fas ligation.
  • Data show that Cartilage oligomeric matrix protein protects cells against death by elevating cIAP2 proteins.
  • cIAP2 mRNA mediates translation only via ribosome bypassing 62 uAUGs. Shunting efficiency was altered by stress & was facilitated by a conserved RNA folding domain (1,470 to 1,877 nucleotides upstream) in a region not scanned by shunting ribosomes.
  • The sequencing analysis of RT-PCR prducts confirmed the presence of the characteristic API2-MALT1 fusion transcript in patients with MALT lymphoma.
  • haem oxygenase-1 plays a central role in NNK-mediated cell proliferation by promoting the expression of p21(Cip1/Waf1/Cid1), inhibitor of apoptosis protein 2 and B-cell lymphoma-2 but inhibiting the activity of Bad
  • XIAP and HIAP-1 in myelin lesions were co-localized with microglia and T cells in multiple sclerosis
  • cIAP1 and cIAP2 promote cancer cell survival by functioning as E3 ubiquitin ligases that maintain constitutive ubiquitination of the RIP1 adaptor protein.
  • c-IAP1 and c-IAP2 are required for TNFalpha-stimulated RIP1 ubiquitination and NF-kappaB activation.
  • Observational study of gene-disease association. (HuGE Navigator)
  • IL-3 up-regulates the expression of the antiapoptotic proteins cIAP2, Mcl-1, and Bcl-X(L) and induces a rapid and sustained de novo expression of the serine/threonine kinase Pim1 that closely correlates with cytokine-enhanced survival.
  • The ubiquitin-associated domain is required for XIAP and CIAP2-MALT1 to activate NF-kappaB.
  • c-IAP2 is consistently overexpressed in nasopharyngeal carcinoma (NPC) cells; study reports that c-IAP2 plays a major role in the resistance of NPC cells to apoptosis induced by TLR3 stimulation
  • PERK activity inhibits the ER stress-induced apoptotic program through the induction of cellular inhibitor of apoptosis (cIAP1 and cIAP2) proteins
  • Methylation and API2/MALT1 fusion in colorectal extranodal marginal zone lymphoma.
  • Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
  • cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation.
  • TRAF2 interaction is critical for c-IAP2/MALT1-mediated increases in the NF-kappaB activity, increased expression of endogenous NF-kappaB target genes and resistance to apoptosis.
  • c-IAP1 can be targeted for degradation by two distinct processes,through degradation of the TRAF2-c-IAP1 heterodimer or through induced autoubiquitination of c-IAP1 by IAP antagonists
  • cIAP2 may therefore play an important role as a target therapy in colorectal cancer
  • Rickettsia rickettsii-induced expression of cIAP2 in host endothelial cells is likely not a major contributor to protection against staurosporine-induced cell death.
  • ARIA knockdown significantly increased inhibitor of apoptosis cIAP-1 and cIAP-2 protein expression
  • Arsenic trioxide suppresses transcription of cIAP2 mRNA in NB-4 cells.
  • Results provide the first structures of BIR domains from human NAIP and cIAP2.
  • Adenosine downregulated the expression of mRNAs and proteins for Bcl-X(L) and inhibitor of apoptosis protein 2 (IAP2) to directly inhibit caspase-3, -7, and -9, but upregulated the expression of mRNA and protein for DIABLO, an inhibitor of IAPs.
  • IAPs could be involved in prostate disorder (BPH, PIN and PC) development since might be provoke inhibition of apoptosis and subsequently cell proliferation
  • API2-MALT1 fusion gene is a distinctive genetic aberration in MALT lymphomas, and is not present in diffuse large B cell lymphoma.
  • virus-triggered ubiquitination of TRAF3 and TRAF6 by cIAP1 and cIAP2 is essential for type I IFN induction and cellular antiviral response
  • crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes; biochemical, structural, and cell biological studies on the interaction between TRAF2 and cIAP2 and on the ability of TRAF1 to modulate this interaction
  • Results describe the complex between baculoviral IAP repeat (BIR) 1 of cIAP1/2 and the coiled-coil region of TRAF2.
  • cancer cell lines evade Smac mimetic-induced apoptosis by up-regulation of cIAP2, which although initially degraded, rebounds. cIAP2 is induced by TNFalpha via NF-kappaB and modulation of the NF-kappaB signal renders cells sensitive to Smac mimetics
  • Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells.
  • Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
  • TTP can bind to the 2nd AU-rich elements of cIAP2 mRNA 3'UTR and destabilize cIAP2 mRNA by forming complexes with Dcp2 and Xrn1.
  • These results support a role for Tax-dependent cIAP-2 expression in preventing the death of naturally infected CD8(+) cells and thereby in their clonal expansion in vivo.
  • cIAP2 upregulated by E6 via EGFR/PI3K/AKT cascades may contribute to cisplatin resistance, revealing that the EGFR or PI3K inhibitor combined with cisplatin may improve the chemotherapeutic efficacy in HPV-infected lung cancer.
  • we confirm that mRNA and protein levels for cIAP2 are highly up-regulated in breast cancer cells by E2 and cytokines
  • TRAF2 and cIAP2 are involved in TWEAK-induced MMP-9 production in fibroblast-like synoviocytes in rheumatoid arthritis.
  • study shows API2-MALT1 fusion oncoprotein induces proteolytic cleavage of NF-kappaB-inducing kinase (NIK); resulting deregulated NIK activity is associated with constitutive noncanonical NF-kappaB signaling, enhanced B cell adhesion and apoptosis resistance
  • Data show that inhibitor-induced rapid degradation of cIAPs requires binding to TRAF2, and reveal an unexpected difference between cIAP1 and cIAP2.
  • Data show that inhibitor of apoptosis protein 1 (cIAP1) and cellular inhibitor of apoptosis protein (cIAP2) expression was significantly increased in bladder cancer compared with normal bladder urothelium.
  • cIAP1/2 are important regulators of inflammatory processes in endothelial cells.
  • The USP19 deubiquitinase regulates the stability of c-IAP1 and c-IAP2.
  • These data reveal a novel mechanism for the inhibition of hepatitis B virus replication by cIAP2 via acceleration of the ubiquitin-proteasome-mediated decay of polymerase.
  • BIRC3 disruption is a common mechanism across marginal zone B-cell lymphomagenesis.
  • cIAP1 and cIAP2 are direct E3 ubiquitin ligases for all four RIP proteins
  • cIAP2 may play an important role in Helicobacter pylori -induced gastric carcinogenesis
  • our results suggest that CpG-induced protection may be mediated by c-IAP-2 through the calcium-activated JNK pathway
  • NF-kappaappaB, acting through two response elements, is required for estrogen receptor recruitment to an adjacent estrogen response element in the BIRC3 promoter.
  • resistance to Vpr-induced apoptosis is specifically mediated by cIAP1/2 genes independent of Bcl-xL and Mcl-1, which play a key role in maintaining cell viability.
  • c-IAP1 and c-IAP2 were required for canonical activation of NF-B and MAPK by members of the TNFR family.
  • The expression of C-IAP2 in hepatocellular carcinoma is associated with tumor recurrence and metastasis.
  • A novel role for cIAP2 in maintaining wild-type p53 levels by preventing both an NFkappaB-mediated increase and IKKalpha/-beta-dependent transcriptional and post-translational modifications of MDM2.
  • we present cIAP-2 as a novel inducer of platinum resistance in ovarian carcinoma cells, and suggest an axis beginning with an encounter between cisplatin and these cells, mediated sequentially by IL-6 and cIAP-2, resulting in cisplatin resistance
  • Clonal evolution from lower to higher risk implicated the emergence of NOTCH1, SF3B1, and BIRC3 abnormalities in addition to TP53 and 11q22-q23 lesions in chronic lymphocytic leukemia.
  • BIRC2 and BIRC3 act as a molecular brake to rein in activation of the JNK signalling pathway and to fine-tune NF-kappaB and JNK signalling to ensure transcriptional responses are appropriately matched to extracellular inputs.
  • BIRC3 gene mutation is associated with chronic lymphocytic leukemia.
  • our study implicates RIP1 ubiquitination as a critical component of API2-MALT1-dependent lymphomagenesis
  • Cytoplasmic expression of HuR is associated with cIAP2 expression in OSCCs
  • palmitate did not decrease cIAP-1 and cIAP-2 mRNA expression in the cells
  • we note that the compounds that sensitize cancer cells to TRAIL are the most efficacious in binding to X-linked IAP, and in inducing cellular-IAP (cIAP)-1 and cIAP-2 degradation
  • increased expression with progression of chronic myeloid leukaemia
  • a number of genes not previously known to be affected by RUNX2 expression, in particular BIRC3, genes encoded on the mitochondrial genome, and several genes involved in bone and tooth formation.
  • Data indicate that silencing of IAPs, IAP1 IAP2 and XIAP, reduced the TRAP-evoked RhoA activation.
  • cisplatin significantly triggered the proteasomal degradation of cellular inhibitor of apoptosis protein 1 and 2 (c-IAP1 and c-IAP2), and X-linked inhibitor of apoptosis (XIAP) in a ROS-dependent manner
  • Distinctive role of c-IAP2 as stabilizer of XIAP, which is likely involved in regulation of NFkappaB activation and apoptosis in GBM cells was determined.
  • Selenite caused CYLD upregulation via LEF1 and cIAP downregulation, both of which contribute to the degradation of ubiquitin chains on RIP1 and subsequent caspase-8 activation and colorectal tumor cell apoptosis.
  • in 11q-deleted patients treated with first-line chemotherapy, ATM mutation rather than BIRC3 deletion and/or mutation identifies a subgroup with a poorer outcome.
  • Data indicate that tumor necrosis factor inducible protein A20-mediated inhibitor of apoptosis protein-2 (cIAP-2) is important in endothelial cell resistance to tumor necrosis factor alpha (TNF-alpha)-induced apoptosis.
  • cIAPs constitutively downregulate PACS-2 by polyubiquitination and proteasomal degradation, thereby restraining TRAIL-induced killing of liver cancer cells
  • XIAP, cIAP1, and cIAP2, members of inhibitor of apoptosis (IAP) proteins, are critical regulators of cell death and survival and are attractive targets for new cancer therapy
  • CIAP1 and cIAP2 represent novel therapeutic targets for the prevention of spontaneous preterm birth.
  • cIAP1 and cIAP2 expression is increased in placenta from women with pre-existing maternal obesity and in response to treatment with pro-inflammatory cytokines
  • Identification and function of the NIK IAP binding motif, which promotes c-IAP1-dependent ubiquitylation of NIK.
  • these findings suggest that GDC-0152 results in human leukemia apoptosis through caspase-dependent mechanisms involving down-regulation of IAPs and inhibition of PI3K/Akt signaling.
  • cIAP2 is in conclusion a regulator of human intestinal wound healing through enhanced migration along with activation of Rac1
  • TNF-alpha induced apoptosis of gastric cancer cells via accelerated degradation of the inhibitor of apoptosis family members, CIAP2, XIAP, and survivin.
  • Data indicate that Smac/DIABLO showed an inverse correlation with inhibitor of apoptosis proteins XIAP, cIAP-1 and cIAP-2.
  • API2-MALT1 induces paracaspase-mediated cleavage of the tumour suppressor protein LIMA1.
  • LapR cells possessed increased levels of 2 of the inhibitors of apoptosis (IAPs), survivin and c-IAP-2, which are reported to block caspase activation downstream of cytosolic cytochrome C release.
  • Data suggest that the seventh zinc finger motif of DNA-binding protein A20 plays important role in NFkappaB-mediated apoptosis induced by tumor necrosis factor-alpha; A20 appears to bind and thus down-regulate inhibitor of apoptosis proteins cIAP1/2.
  • these results indicate that N. gonorrhoeae stimulation of human endocervical epithelial cells induces the release of cIAP2, an essential regulator of cell death and immune signaling.
  • this study candidates BIRC3 as one of the potentially useful predictive marker for discriminating patients with oesophageal and oesophagogastric junction adenocarcinoma who will most likely benefit from preoperative chemoradiotherapy.
  • cIAP2 is upregulated in regenerative epithelial cells both in ulcerative colitis and in experimental intestinal wounds. Inhibition of cIAP2 decreases wound healing in vitro possibly through inhibition of migration. [review]
  • High BIRC3 expression is associated with pancreatic cancer.
  • The clinical impact of small subclones harboring NOTCH1, SF3B1, or BIRC3 mutations in chronic lymphocytic leukemia patients appears to be less pronounced than that of small TP53 mutated subclones.
  • Study demonstrate that BIRC3 expression increases secondary to acquisition of temozolomide TMZ and irradiation resistance in glioblastoma.
  • cIAP1 and cIAP2 mediate BCL10 ubiquitination essential for BCR-dependent NF-kB activity in the ABC subtype of DLBCL. cIAP1/2 attach K63-linked polyubiquitin chains on themselves and on BCL10, recruiting IKK and LUBAC essential for IKK activation.
  • We show that BIRC3 has a unique role in facilitating glioma progression from low- to high-grade
  • Results indicate that Pellino-1 contributes to lung oncogenesis through the overexpression of inhibitor of apoptosis protein 2 (cIAP2) and promotion of cell survival and chemoresistance.
  • The expression of cIAP2 mRNA was significantly higher in the groups with Helicobacter pylori(+), atrophic gastritis/intestinal metaplasia(+), and Helicobacter pylori-positive early gastric cancer than in the control, Helicobacter pylori(+), and atrop [...]
  • Polymorphisms in the BIRC3 gene are associated with a protective effect with regards to asthma susceptibility, and a reduced load of inflammatory cells.
  • Network analysis identified BIRC3 as pathogenic gene in childhood asthma.
  • destabilization of TRAF2 by miR-17 reduced the ability of TRAF2 to associate with cIAP2, resulting in the downregulation of TNF-alpha-induced NF-kappaBp65, c-Jun, and STAT3 nuclear translocation and the production of IL-6, IL-8, MMP-1, and MMP-13 in [...]
  • CIAP2 expression was elevated in human GBC tissues.
  • we indicated that miR-34a can inhibit tumor invasion and metastasis in osteosarcoma, and its mechanism may be partly related to downregulating the expression of C-IAP2 and Bcl-2 protein directly or indirectly.
  • we have uncovered a novel role for BIRC3 as a targetable biomarker and mediator of hypoxia-driven habitats in GBM.
  • High BIRC3 expression is associated with Oral squamous cell carcinoma.
  • NAIP expression is most abundant in M2 macrophages, while cIAP1 and cIAP2 show an inverse pattern of expression in polarized cells, cIAP2 is preferentially expressed in M1-macrophages and cIAP1 in M2-macrophages. IAP antagonist treatment of resting M [...]
  • BIRC3 induces tumor proliferation and metastasis in vitro and in vivo. BIRC3 may serve as a novel therapeutic target for liver cancer.
  • Sensitization and reversal of glioblastoma cells resistance to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism has been reported.
  • Experimental results demonstrated that cIAP2 regulated the expression of p53 and thus was likely to be a potential mechanism for evironmental pollutant perfluorodecanoic acidinduced inhibition of gastric cell senescence resulted in growth promotion r [...]
  • Study shows the impact of BIRC3 expression in chronic lymphocytic leukemia disease progression in the absence of BIRC3 mutations and shows altered canonical NF-kappaB target gene activation with therapeutic implications.
  • HuR mediated overexpression of IAP1 significantly correlates with poor outcomes and early progression of pancreatic cancer.
  • We investigated the function of the long BIRC3 3' UTR, which is upregulated in leukemia. The 3' UTR does not regulate BIRC3 protein localization or abundance but is required for CXCR4-mediated B cell migration. We established an experimental pipeline [...]
  • Results found that BIRC3 was upregulated in triple-negative breast cancer (TNBC) cell lines and specimens. HCP5 competitive sponging of miR-219, BIRC3 target, leads to activation of BIRC3 in apoptosis signaling pathway to promote TNBC progression.
  • Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia.
  • The findings identify ZFAND2A/AIRAP as a novel stress-regulated survival factor implicated in the stabilization of the antiapoptotic protein cIAP2 and as a new potential therapeutic target in melanoma
  • Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial.
  • SURF4 maintains stem-like properties via BIRC3 in ovarian cancer cells.
  • A20 Promotes Ripoptosome Formation and TNF-Induced Apoptosis via cIAPs Regulation and NIK Stabilization in Keratinocytes.
  • Future Therapeutic Directions for Smac-Mimetics.
  • Increased Expression of BIRC2, BIRC3, and BIRC5 from the IAP Family in Mesenchymal Stem Cells of the Umbilical Cord Wharton's Jelly (WJSC) in Younger Women Giving Birth Naturally.
  • WTAP and BIRC3 are involved in the posttranscriptional mechanisms that impact on the expression and activity of the human lactonase PON2.
  • cIAP2 via NF-kappaB signalling affects cell proliferation and invasion in hepatocellular carcinoma.
  • Regulation of Anti-Apoptotic SOD2 and BIRC3 in Periodontal Cells and Tissues.
  • Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas.
  •   MGD
  • cellular phenotype
  • homeostasis/metabolism phenotype
  • immune system phenotype
  • muscle phenotype
  • normal phenotype
  • mortality/aging
  • cardiovascular system phenotype
  • hematopoietic system phenotype
  •   transcripts ENST00000263464: 5197 bases (protein_coding)
    ENST00000532808: 4238 bases (protein_coding)
    ENST00000527336: 664 bases (retained_intron)
    ENST00000526421: 624 bases (processed_transcript)
    ENST00000528940: 607 bases (processed_transcript)
    ENST00000527309: 549 bases (protein_coding)
      interactions (STRING)
    AIFM1: (textmining 649)    AKT1: (textmining 740)    ANAPC11: (textmining 428)    ANXA5: (textmining 704)   
    APAF1: (textmining 853)    ATF3: (textmining 491)    AVEN: (textmining 408)    BAG5: (textmining 462)   
    BAK1: (textmining 732)    BAX: (textmining 792)    BCL10: (textmining,experimental 634)    BCL2: (textmining 749)   
    BCL2A1: (textmining 740)    BCL2L1: (textmining 744)    BCL2L2: (textmining 577)    BFAR: (textmining 496)   
    BID: (textmining 457)    BIRC2: binding,reaction (reactome,kegg_pathways 999)    BLK: (textmining 450)    BNIP1: (textmining 409)   
    BNIP3: (textmining 532)    BRMS1: (textmining 419)    CALM3: (textmining 800)    CAPNS1: (textmining 413)   
    CARD9: (textmining 401)    CASP10: (textmining 579)    CASP2: (textmining 654)    CASP3: (textmining,experimental 845)   
    CASP4: (textmining 568)    CASP6: (textmining 597)    CASP7: (textmining,experimental 854)    CASP8: (textmining 797)   
    CASP9: (textmining,experimental 894)    CCL2: (textmining 478)    CCND1: (textmining 687)    CCND2: (textmining 601)   
    CD68: (textmining 457)    CDH13: (textmining 495)    CDK4: (textmining 435)    CFLAR: (textmining 809)   
    CHUK: (textmining 624)    CIDEB: (textmining 485)    COMMD1: (textmining 451)    CORT: (textmining 507)   
    CSF2: (textmining 839)    CSF3: (textmining 825)    CXCL9: (textmining 454)    CYCS: (textmining 787)   
    CYLD: (textmining 661)    DAD1: (textmining 491)    DIABLO: (textmining,experimental 950)    DUSP8: (textmining 462)   
    DUT: (textmining 661)    EML4: (textmining 451)    FADD: (textmining 793)    FAIM: (textmining 408)   
    FAS: (textmining 850)    FASLG: (textmining 720)    GADD45A: (textmining 534)    GADD45B: (textmining 445)   
    GJB2: (textmining 623)    GNG11: (textmining 562)    GSPT1: (experimental 619)    HDAC7: (textmining 502)   
    HMOX1: (textmining 482)    HTRA2: (textmining,experimental 851)    IER3: (textmining 653)    IKBKB: (textmining 761)   
    IKBKG: (textmining 696)    IL1B: (textmining 518)    IL5: (textmining 817)    IL8: (textmining 556)   
    JAK2: (textmining 430)    KCNJ11: (textmining 943)    KCNJ6: (textmining 665)    KDM4B: (textmining 502)   
    KRIT1: (textmining 817)    KRR1: (textmining 633)    LAMA4: (textmining 422)    LGALS9: (textmining 485)   
    LPXN: (textmining 446)    LTBR: (textmining 527)    MADD: (textmining 415)    MALT1: (textmining 742)   
    MAPK10: (textmining 492)    MAPK11: (textmining 417)    MAPK12: (textmining 417)    MAPK14: (textmining 426)   
    MAPK8: (textmining 749)    MAPK9: (textmining 492)    MCL1: (textmining 740)    MYC: (textmining 510)   
    MYCL1: (textmining 492)    MYO1E: (textmining 518)    NFKB1: (textmining 682)    NFKB2: (textmining 693)   
    NFKBIA: (textmining 792)    NOD1: (textmining 460)    NR2E3: (textmining 840)    PARP1: (textmining 698)   
    PAWR: (textmining 486)    PIK3R3: (textmining 412)    PRDM15: (textmining 579)    PRRG1: (textmining 548)   
    PSAP: (textmining 423)    RAF1: (textmining,experimental 615)    RBM5: (textmining 408)    REG3G: (textmining 537)   
    REL: (textmining 694)    RELA: (textmining 864)    RELB: (textmining 695)    RIPK1: (textmining,experimental 688)   
    RIPK2: (textmining,experimental 662)    RNF8: (textmining 409)    SAT1: (textmining 409)    SIRT6: (experimental 624)   
    SMARCD3: (textmining 469)    STAT3: (textmining 647)    TAB1: (textmining 496)    TANK: (textmining 509)   
    TBL1XR1: (textmining 401)    TIFA: (textmining 496)    TNFAIP1: (textmining 457)    TNFAIP2: (textmining 457)   
    TNFAIP3: (textmining 786)    TNFAIP8: (textmining 609)    TNFAIP8L1: (textmining 457)    TNFAIP8L2: (textmining 457)   
    TNFAIP8L3: (textmining 457)    TNFRSF1A: (textmining,experimental 950)    TNFRSF1B: (textmining 810)    TNFRSF21: (textmining 532)   
    TNFRSF8: (textmining 400)    TNFRSF9: (textmining 427)    TNFSF10: (textmining 968)    TNFSF15: (textmining 470)   
    TONSL: (textmining 618)    TP53: (textmining 775)    TRADD: (textmining 746)    TRAF1: (textmining,experimental 946)   
    TRAF2: (textmining,experimental 989)    TRAF3: binding (NLP 980)    TRAF4: (textmining 706)    TRAF5: (textmining 638)   
    TRAF6: (textmining 699)    TUSC3: (textmining 480)    UBC: (textmining,experimental 693)    UBE2D1: (textmining 441)   
    UBE2D2: (textmining,experimental 636)    UBE2E1: (textmining 401)    UBE2L3: (textmining 706)    UBE3A: (textmining 655)   
    XAF1: (textmining,experimental 930)    XIAP: binding (kegg_pathways 997)    YWHAH: (textmining 454)    ZFYVE20: (textmining 475)   
  • toll-like receptor signaling pathway
  • MyD88-independent toll-like receptor signaling pathway
  • ubiquitin-protein ligase activity
  • protein binding
  • nucleus
  • cytoplasm
  • cytosol
  • apoptotic process
  • cell surface receptor signaling pathway
  • spermatogenesis
  • metabolic process
  • zinc ion binding
  • protein ubiquitination
  • positive regulation of protein ubiquitination
  • regulation of toll-like receptor signaling pathway
  • toll-like receptor 3 signaling pathway
  • toll-like receptor 4 signaling pathway
  • TRIF-dependent toll-like receptor signaling pathway
  • NIK/NF-kappaB signaling
  • regulation of RIG-I signaling pathway
  • negative regulation of phosphorylation
  • regulation of apoptotic process
  • negative regulation of apoptotic process
  • positive regulation of I-kappaB kinase/NF-kappaB signaling
  • protein complex
  • innate immune response
  • regulation of innate immune response
  • membrane raft
  • regulation of inflammatory response
  • protein heterooligomerization
  • regulation of necroptotic process
  • negative regulation of necroptotic process
  • necroptotic process
  • regulation of nucleotide-binding oligomerization domain containing signaling pathway
  • regulation of cysteine-type endopeptidase activity
  • negative regulation of reactive oxygen species metabolic process
  • 1 gene(s) (35.759 ms).


    your settings in the query mask this output

    create a BED file

    I want to sequence only the candidate genes shown here, only exons
    complete genes
    flanked by bases on each side.

    citing GeneDistiller

    If you feel that GeneDistiller has helped you in your research, please cite the following publication:

    Seelow D, Schwarz JM, Schuelke M.
    GeneDistiller--distilling candidate genes from linkage intervals.
    PLoS ONE. 2008;3(12):e3874. Epub 2008 Dec 5.

    entitylast update (YYYY-MM-DD)
    Disease Ontology2020-06-29
    Ensembl 84 (GRCh73)2016-06-14
    Entrez gene history2021-10-28
    Entrez gene positions2021-10-28
    Entrez gene RIFS2021-10-28
    Entrez genes2021-10-28
    Entrez gene synonyms2021-10-28
    Human Phenotype Ontology2015-12-22